Lmcg Investments LLC Acquires 96,793 Shares of Baxter International Inc. $BAX

Lmcg Investments LLC acquired a new stake in shares of Baxter International Inc. (NYSE:BAX) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 96,793 shares of the medical instruments supplier’s stock, valued at approximately $2,323,000.

A number of other institutional investors have also recently made changes to their positions in BAX. BlackRock Inc. acquired a new position in Baxter International during the 2nd quarter valued at about $1,744,874,000. Pzena Investment Management LLC purchased a new stake in Baxter International in the second quarter valued at about $1,392,098,000. Equity Investment Corp purchased a new stake in Baxter International in the second quarter valued at about $146,815,000. Bank of America Corp DE acquired a new stake in Baxter International in the second quarter worth about $132,993,000. Finally, Bank of New York Mellon Corp acquired a new stake in Baxter International in the second quarter worth about $68,036,000. Institutional investors and hedge funds own 90.19% of the company’s stock.

Baxter International Price Performance

Shares of BAX opened at $24.74 on Thursday. The firm has a market capitalization of $12.79 billion, a PE ratio of -11.95, a price-to-earnings-growth ratio of 3.71 and a beta of 0.65. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32. The company’s fifty day moving average price is $24.81 and its 200-day moving average price is $22.06. Baxter International Inc. has a 1-year low of $15.73 and a 1-year high of $30.00.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The company had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $2.80 billion. During the same quarter in the previous year, the firm posted $0.59 EPS. The firm’s revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, equities research analysts predict that Baxter International Inc. will post 2.04 EPS for the current year.

Baxter International Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were paid a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, August 28th. Baxter International’s dividend payout ratio (DPR) is presently -1.93%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on BAX. Wolfe Research began coverage on Baxter International in a research note on Tuesday. They set a “peer perform” rating on the stock. Barclays initiated coverage on shares of Baxter International in a report on Wednesday, October 7th. They set an “underweight” rating and a $20.00 price objective on the stock. Citigroup decreased their price objective on shares of Baxter International from $28.00 to $27.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. TD Cowen lifted their target price on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research note on Monday, July 27th. Finally, Wall Street Zen cut shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Saturday, October 10th. One investment analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $21.73.

Baxter International Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.